Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Azvudine - Zhengzhou Granlen PharmaTech

Next Previous
Drug Profile

Azvudine - Zhengzhou Granlen PharmaTech

Alternative Names: FNC; Jie Bei An

Latest Information Update: 09 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Zhengzhou University
  • Developer HeNan Sincere Biotech Co. Ltd; Shanghai Henlius Biotech; Zhengzhou Granlen PharmaTech
  • Class Antiretrovirals; Antivirals; Azides; Fluorinated hydrocarbons; Pyrimidinones; Small molecules
  • Mechanism of Action Nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered COVID-19 pneumonia; HIV infections
  • Phase III COVID 2019 infections

Most Recent Events

  • 20 May 2025 Genuine Biotech initiates enrolment in a phase II pharmacokinetics trial in China (PO, Tablet) (NCT07001436)
  • 20 Mar 2025 Henan Genuine Biotech completes a phase I pharmacokinetics trial in China (PO) (NCT07002281)
  • 22 Jul 2024 Henan Genuine Biotech initiates enrolment in a phase I pharmacokinetics trial in China (PO) (NCT07002281)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top